Oncottack™ Process Introduces
Personalized Cancer Vaccine
-
Created and developed by the team at Oncottack™ Process consisting of a highly experienced veterinarian and an immunologist scientist.
-
Partially subsidized by the parent company of Oncottack™ Process.
-
Offering now open to patients in only the Chicago metro area.
-
A painless and economical approach to managing and treating solid cancers in dogs and cats.
-
Involves sending a sample of the resected malignant tumor mass to us and receiving a set of 7 injections to be administered subcutaneously at 0 day, 3 weeks, 6 weeks, 3 months, 6 months, 9 months and 12 months.
-
Samples will also be banked for future use for the more tenacious tumors.
-
A clinical report of effectiveness will have to be submitted by the Veterinarian one year after the initiation of the treatment.
-
Please review the eligibility criteria and subsidized cost of admission in the trial with your veterinarian.